| REPORT ATTRIBUTE |
DETAILS |
| Historical Period |
2020-2023 |
| Base Year |
2024 |
| Forecast Period |
2025-2032 |
| Placenta Extract Market Size 2024 |
USD 54.7 million |
| Placenta Extract Market, CAGR |
4.6% |
| Placenta Extract Market Size 2032 |
USD 78.3 million |
Market Overview:
The Placenta Extract Market is projected to grow from USD 54.7 million in 2024 to USD 78.3 million by 2032, registering a compound annual growth rate (CAGR) of 4.6% during the forecast period.
The Placenta Extract Market is driven by growing consumer awareness of the therapeutic and cosmetic benefits of placenta-based products, particularly in skincare and anti-aging applications. The rising demand for natural and bioactive ingredients in personal care formulations has significantly boosted market interest, especially among aging populations and wellness-focused consumers. Increasing research and development activities, along with technological advancements in extraction and formulation processes, are enhancing product efficacy and safety, further supporting market expansion. Additionally, the expanding use of placenta extract in pharmaceuticals for its regenerative and healing properties contributes to its growing adoption. Trends such as the rise of K-beauty, clean-label products, and holistic wellness solutions continue to shape consumer preferences, creating new growth avenues. Regulatory approvals and supportive government policies in some regions are also helping companies expand their product portfolios. Moreover, the growing e-commerce sector has enabled broader accessibility to placenta-based products, reinforcing market penetration across emerging economies and niche consumer segments.
The Placenta Extract Market is geographically diverse, with significant market shares in North America, Europe, Asia-Pacific, and emerging regions like Latin America and the Middle East & Africa. North America holds a notable share, driven by advanced healthcare and cosmetic industries, while Europe benefits from strong demand for ethically sourced personal care products. Asia-Pacific leads with the highest market share, driven by high consumer acceptance in countries like Japan, South Korea, and China. Latin America and the Middle East & Africa are growing markets, with rising awareness and demand for wellness products. Leading players in these regions, such as BIOFAC, Swanson Health, Albert David Ltd., and Galtec Australia, are strategically expanding their presence and innovating to cater to regional preferences, driving the overall growth of the global placenta extract market.
Access crucial information at unmatched prices!
Request your sample report today & start making informed decisions powered by Credence Research!
Download Sample
Market Insights:
- The Placenta Extract Market is projected to grow from USD 54.7 million in 2024 to USD 78.3 million by 2032, with a CAGR of 4.6% during the forecast period.
- Rising consumer awareness of the regenerative and anti-aging benefits of placenta extract is driving market growth, particularly in skincare and wellness applications.
- Increasing demand for natural, bioactive ingredients in personal care products is boosting market interest, especially among aging populations.
- Advancements in extraction and processing technologies are improving product efficacy, safety, and scalability, enhancing market opportunities.
- The placenta extract market is expanding in pharmaceuticals due to its regenerative and healing properties, supporting its use in medical applications.
- Favorable regulatory frameworks and growing acceptance of placenta-derived ingredients in key regions are encouraging market expansion.
- The Asia-Pacific region leads with a 42% market share in 2024, followed by North America (21%) and Europe (19%), with emerging growth in Latin America and the Middle East & Africa.
Market Drivers:
Rising Demand for Natural and Bioactive Ingredients:
The increasing consumer preference for natural and bioactive compounds in health and beauty products is a major driver of the placenta extract market. Placenta extract, known for its rich composition of proteins, amino acids, and bioactive peptides, is widely recognized for its regenerative and anti-aging properties. Consumers are increasingly turning to such naturally derived ingredients to address skin health, reduce signs of aging, and support overall wellness. This trend is particularly strong in premium skincare and cosmeceutical products, where users seek effective yet gentle alternatives to synthetic chemicals.
For instance, Japan Bio Products’ Laennec PO Human Placenta Extract is promoted for its youth-preserving benefits and is widely used in Japan for skin rejuvenation therapies.
Expanding Applications in Pharmaceuticals and Therapeutics:
Beyond cosmetic uses, placenta extract is gaining traction in the pharmaceutical and medical sectors due to its therapeutic benefits. Its regenerative capabilities support tissue repair, wound healing, and anti-inflammatory treatments, making it valuable in clinical applications. Researchers and healthcare providers are exploring placenta-based formulations for conditions ranging from chronic ulcers to liver disorders. As scientific validation increases, the medical use of placenta extract is expected to grow, further diversifying market opportunities.
For instance, Hominis placenta pharmacopuncture, a placenta-based therapy, has been investigated in randomized, placebo-controlled trials for alleviating perimenopausal symptoms such as hot flashes, showing measurable improvements in patient outcomes.
Advancements in Extraction and Processing Technologies:
Technological innovations in extraction and purification methods have significantly improved the safety, potency, and shelf-life of placenta extract products. Companies are investing in advanced biotechnological processes to ensure high-quality yields while maintaining bioactivity. These innovations not only enhance product performance but also meet rising regulatory and consumer standards for quality and transparency. The improved scalability and efficiency of production processes have made placenta extract more accessible and commercially viable across multiple industries.
Supportive Regulatory Frameworks and Market Expansion:
Favorable regulations and growing acceptance of placenta-derived ingredients in various countries are contributing to market growth. Governments and regulatory bodies in regions such as Asia-Pacific and Europe are establishing clear guidelines for the use of human and animal placenta in consumer products. This clarity supports product innovation and international trade, encouraging companies to expand their product lines and enter new markets. The growing popularity of e-commerce platforms has further accelerated product availability and consumer outreach globally.
Market Trends:
Growth in Cosmetic and Skincare Applications:
The placenta extract market is witnessing a strong surge in cosmetic and skincare applications due to rising consumer interest in anti-aging and regenerative formulations. Placenta-based ingredients are now commonly included in serums, creams, and facial masks for their ability to promote skin rejuvenation, enhance elasticity, and reduce wrinkles. With an increasing demand for effective and natural alternatives to synthetic compounds, cosmetic manufacturers are incorporating placenta extract to meet the expectations of wellness-conscious consumers seeking premium and functional skincare solutions.
For instance, MZ Skin’s REST & REVIVE Restorative Placenta & Stem Cell Night Serum, which uses ovine placenta and plant stem cells, is clinically proven to decrease wrinkle depth by up to 14.4% after one month, with 100% of users reporting improved skin smoothness and a 20% increase in skin hydration after 30 days.
Rising Popularity of K-Beauty and J-Beauty Products:
Asian beauty trends, particularly from Korea and Japan, continue to influence global skincare markets, with placenta extract playing a key role in many of these formulations. These trends emphasize innovation, natural ingredients, and scientifically backed products, aligning well with the benefits offered by placenta extract. The global adoption of K-beauty and J-beauty has helped normalize placenta-based ingredients, encouraging Western brands to integrate similar solutions in their product lines to stay competitive.
For instance, Japan Bio Products’ Laennec PO Human Placenta Extract is a documented supplement marketed for maintaining youthfulness and supporting skin health, reflecting the mainstream acceptance of placenta-based ingredients in Japanese beauty routines.
Increased Focus on Ethical and Sustainable Sourcing:
As consumers become more conscious of ethical sourcing and sustainability, placenta extract producers are shifting towards transparent supply chains and humane collection methods. Companies are increasingly adopting certifications and clean-label standards to reassure customers regarding product safety, origin, and production practices. This shift not only addresses consumer concerns but also enhances brand reputation and trust in the long term, fostering loyalty in a competitive and evolving market.
Expansion Through E-Commerce and Direct-to-Consumer Models:
E-commerce has become a vital channel for placenta extract products, offering global consumers easy access to niche and specialty formulations. Direct-to-consumer brands are leveraging digital platforms to educate buyers about product benefits and build personalized experiences. This online presence allows for better customer engagement and market reach, helping brands scale efficiently and tap into emerging markets worldwide.
Market Challenges Analysis:
Ethical Concerns and Regulatory Hurdles:
The placenta extract market faces significant challenges related to ethical concerns and complex regulatory landscapes. The sourcing of placenta, whether human or animal, raises moral questions that can affect consumer perception and product acceptance. Human placenta extraction, in particular, involves sensitive issues such as donor consent, medical ethics, and cultural or religious opposition, which vary across regions and populations. On the other hand, animal-derived placenta faces scrutiny from animal rights groups and conscious consumers who are increasingly focused on cruelty-free and vegan product alternatives. These concerns can deter large consumer segments and limit market penetration. Additionally, varying global regulations add another layer of complexity. While some countries permit the use of placenta extract with strict guidelines, others impose bans or extensive regulatory barriers, making international trade and product registration cumbersome. Ensuring compliance with each region’s safety, labeling, and sourcing regulations increases operational costs, delays product launches, and restricts scalability, especially for smaller firms.
For instance, BIOFAC A/S, a leading Scandinavian manufacturer, supplies sheep placenta extract for use in premium skincare and pharmaceutical formulations, but must comply with strict European Union regulations on animal-derived ingredients, including detailed traceability and labeling requirements.
Limited Public Awareness and Scientific Validation:
A major challenge in the placenta extract market is the limited public awareness and insufficient scientific validation of its claimed benefits. Although placenta extract is marketed for its regenerative, anti-aging, and therapeutic properties, much of the supporting evidence remains anecdotal or derived from traditional medicine. This lack of rigorous, peer-reviewed scientific studies hinders mainstream acceptance, especially in medical and pharmaceutical sectors. Consumers often hesitate to adopt placenta-based products due to cultural stigmas, misinformation, or safety concerns. The absence of standardized formulations and dosage recommendations further complicates consumer trust and consistent product performance. Healthcare professionals and dermatologists are also reluctant to endorse placenta-derived products without clear clinical backing. As regulatory agencies demand stronger evidence to approve therapeutic claims, the burden of proof lies heavily on manufacturers. Investment in high-quality research, clinical trials, and educational campaigns will be essential for companies to establish credibility, dispel misconceptions, and build consumer confidence in this emerging market segment.
Market Opportunities:
The placenta extract market presents promising opportunities driven by the growing global demand for advanced skincare and wellness products. As consumers increasingly prioritize natural, effective, and multifunctional ingredients, placenta extract stands out for its regenerative, hydrating, and anti-aging properties. Emerging markets in Asia-Pacific, Latin America, and the Middle East offer significant growth potential due to rising disposable incomes, expanding beauty and personal care industries, and increased awareness of high-performance cosmeceuticals. Companies that tailor their product offerings to suit regional preferences and cultural sensitivities can successfully tap into these expanding demographics. Additionally, as clean beauty trends continue to influence consumer behavior, placenta-based products with transparent sourcing, ethical processing, and minimal additives can gain strong traction among health-conscious and eco-aware buyers. Expanding product formats, such as serums, supplements, and injectables, also provide avenues for innovation and market differentiation.
The integration of placenta extract into therapeutic and pharmaceutical applications offers another high-potential avenue for market growth. Increasing scientific interest in placenta’s bioactive compounds, including growth factors, peptides, and cytokines, supports its potential use in regenerative medicine, wound care, and chronic skin condition treatments. Collaborations between biotech firms, research institutions, and pharmaceutical companies can accelerate product development and clinical validation, broadening the extract’s medical applicability. Furthermore, as consumers increasingly adopt nutraceuticals and functional foods, placenta-based oral supplements present a new frontier for market expansion. Brands that invest in education, clear communication of benefits, and safety assurance can attract a wider audience across both medical and wellness segments. Advancements in biotechnology and improved extraction techniques will further enable scalable production while preserving bioactivity, ensuring a sustainable supply chain. With growing interest in innovative, nature-based therapies, the placenta extract market holds substantial opportunities for players willing to invest in science-driven, ethically aligned product strategies.
Market Segmentation Analysis:
By Type
The placenta extract market is segmented into liquid extract, powder extract, and capsules/tablets. Liquid extracts dominate due to their widespread use in cosmetics and topical applications, offering quick absorption and efficacy. Powder forms are favored for longer shelf life and easy integration into formulations, while capsules/tablets are growing in popularity in nutraceuticals.
By Source
Based on source, the market is categorized into human placenta extract and animal placenta extract. Human placenta extract is preferred in premium cosmetic and medical products due to its perceived biological compatibility and efficacy. Animal placenta extract, particularly from sheep and pigs, remains cost-effective and widely used in both mass-market cosmetics and supplements.
By Application
In terms of application, cosmetics and personal care lead the market, driven by rising demand for anti-aging and skin-repair products. Pharmaceuticals follow, supported by research in regenerative medicine. Food and beverages represent a niche but emerging segment, especially in Asia, while “others” include wellness supplements and specialty health products.
Segments:
Based on Type
- Liquid Extract
- Powder Extract
- Capsules/Tablets
Based on Source
- Human Placenta Extract
- Animal Placenta Extract
Based on Application
- Cosmetics and Personal Care
- Pharmaceuticals
- Food and Beverages
- Others
Based on End-User
- Individual Consumers
- Commercial Use
Based on the Geography:
- North America
- Europe
- Germany
- France
- U.K.
- Italy
- Spain
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- South-east Asia
- Rest of Asia Pacific
- Latin America
- Brazil
- Argentina
- Rest of Latin America
- Middle East & Africa
- GCC Countries
- South Africa
- Rest of the Middle East and Africa
Regional Analysis:
North America
North America holds a notable share in the placenta extract market, accounting for 21% of the global market in 2024. The region’s strong position is supported by advanced healthcare infrastructure, rising consumer demand for anti-aging and wellness products, and a well-established cosmetics industry. The U.S. leads this regional growth, driven by increasing investments in R&D, high consumer awareness, and the popularity of clean beauty trends. Additionally, the presence of major pharmaceutical and cosmetic manufacturers accelerates product innovation and commercialization. Regulatory support for natural and bioactive ingredients has also contributed to increased market penetration.
Europe
Europe accounts for 19% of the global placenta extract market share in 2024. The region benefits from strong demand for ethically sourced, premium personal care products and therapeutic solutions. Countries like Germany, France, and the UK are at the forefront of this trend, with consumers showing a strong preference for functional skincare and bioactive supplements. Strict regulatory standards in the EU drive manufacturers to focus on product safety and transparency, which has positively impacted consumer trust. The pharmaceutical industry’s growing interest in natural therapeutics further supports market growth in this region.
Asia-Pacific
Asia-Pacific dominates the placenta extract market with a commanding 42% share in 2024. The region’s leadership stems from high consumer acceptance of placenta-based products, especially in Japan, South Korea, and China. These countries have long traditions of incorporating placenta extract into cosmetics and health supplements, which aligns with cultural preferences for natural and holistic remedies. Rapid urbanization, rising disposable incomes, and a booming beauty industry have further propelled market expansion. Additionally, regional manufacturers are capitalizing on low production costs and technological advancements to offer a diverse range of products for domestic and international markets.
Latin America and Middle East & Africa
Latin America holds 9% of the global placenta extract market in 2024, with Brazil and Mexico emerging as key contributors. Increasing awareness of skincare benefits and expanding e-commerce platforms are supporting regional growth. Meanwhile, the Middle East & Africa region accounts for 9% of the market. Countries such as South Africa and the UAE are witnessing growing demand for premium beauty and wellness products. However, limited regulatory clarity and slower adoption of placenta-based therapies may restrict growth potential. Nevertheless, rising health consciousness and the influence of global beauty trends are gradually opening opportunities in both regions.
Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!
Key Player Analysis:
- Galtec Australia
- Biostem Technologies
- Swanson Health
- Japan Natural Laboratories
- Albert David Ltd.
- Ai-Zest
- MZ Skin Limited
- Alchem International Pvt Ltd
- BIOFAC
- Agri-lab
- Bicontinental
- Japan Bio
Competitive Analysis:
The placenta extract market is highly competitive, with several established players actively driving innovation and market growth. Leading companies such as BIOFAC, Swanson Health, Albert David Ltd., Bicontinental, Galtec Australia, Agri-lab, Japan Natural Laboratories, Ai-Zest, Japan Bio, MZ Skin Limited, Biostem Technologies, and Alchem International Pvt Ltd. are focusing on expanding their product portfolios and enhancing their market presence. These companies are leveraging advanced extraction technologies, investing in research and development, and catering to growing consumer demand for natural, bioactive ingredients in cosmetics, pharmaceuticals, and wellness products. They are also emphasizing ethical sourcing and transparency in their manufacturing processes to align with rising consumer preferences for clean and cruelty-free products. The increasing focus on e-commerce platforms and direct-to-consumer sales models allows these companies to reach global markets efficiently, while strategic partnerships, collaborations, and regulatory compliance further strengthen their competitive positioning. As market demand increases, these players continue to innovate and maintain a competitive edge.
Recent Developments:
- On May 12, 2025, BioStem Technologies announced the initiation of a new clinical trial for its BioREtain® Amnion Chorion (BR-AC) product for venous leg ulcers, the launch of a clinical trial for Vendaje® (an amniotic membrane product) in diabetic foot ulcers, and the expansion of its intellectual property portfolio to 55 issued and 52 pending patents, reinforcing its leadership in placental-derived wound care solutions.
- In 2023, Galtec Australia focused on strengthening its product portfolio and expanding its business in the global sheep placenta extract market, with particular emphasis on dietary, pharmaceutical, and cosmetic applications.
- In May 2025, BIOFAC continued to emphasize its GMP-certified placenta extract, particularly for dermatological applications such as wound healing, highlighting its beneficial role as a topical agent for chronic non-healing wounds.
Market Concentration & Characteristics:
The placenta extract market exhibits a moderate level of concentration, with several key players controlling a significant share of the market. These companies are focusing on expanding their product portfolios, technological advancements, and geographical reach to secure their competitive position. Market players often operate in diverse sectors, including cosmetics, pharmaceuticals, and nutraceuticals, leveraging their expertise in bioactive ingredient extraction and formulation. The market is characterized by strong R&D investments aimed at improving product quality and safety while addressing consumer demand for natural, ethical, and sustainable products. While established brands dominate, there is increasing competition from regional and smaller players who are capitalizing on niche markets and offering cost-effective solutions. The growing trend of e-commerce has also introduced new opportunities for market penetration, enabling both large and small manufacturers to access a broader consumer base globally. Overall, innovation and ethical practices are key differentiators in this market.
Report Coverage:
The research report offers an in-depth analysis based on Type, Source, Application, End-User and Geography. It details leading market players, providing an overview of their business, product offerings, investments, revenue streams, and key applications. Additionally, the report includes insights into the competitive environment, SWOT analysis, current market trends, as well as the primary drivers and constraints. Furthermore, it discusses various factors that have driven market expansion in recent years. The report also explores market dynamics, regulatory scenarios, and technological advancements that are shaping the industry. It assesses the impact of external factors and global economic changes on market growth. Lastly, it provides strategic recommendations for new entrants and established companies to navigate the complexities of the market.
Future Outlook:
- The placenta extract market is expected to continue expanding as consumer demand for natural and bioactive ingredients in skincare and wellness products grows.
- Advances in extraction technologies will enhance product quality, safety, and efficacy, contributing to increased market acceptance.
- The use of placenta extract in pharmaceutical applications, particularly for regenerative medicine and wound healing, will open new avenues for market growth.
- The rising focus on clean beauty and ethical sourcing will drive more brands to incorporate placenta extract into their product offerings.
- Increased awareness and education about the benefits of placenta extract will help overcome skepticism and boost market adoption.
- E-commerce will play a crucial role in expanding access to placenta-based products, allowing companies to reach a global audience.
- There will be a growing emphasis on cruelty-free and vegan alternatives, leading to innovation in plant-based placenta extracts.
- Regulatory frameworks will continue to evolve, ensuring product safety while providing a clearer path for international market expansion.
- New product formats, including oral supplements and injectables, will diversify the range of placenta-based offerings.
- Emerging markets in regions like Latin America and the Middle East will present significant growth opportunities due to increasing demand for premium wellness products.
